Why Is United Therapeutics (UTHR) Up 22.1% Since Last Earnings Report?Zacks Investment Research • 06/03/22
United Therapeutics Corporation (UTHR) CEO Martine Rothblatt on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/04/22
United Therapeutics (UTHR) Q1 Earnings and Revenues Surpass EstimatesZacks Investment Research • 05/04/22
United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the 2022 American Thoracic Society International ConferenceBusiness Wire • 04/29/22
United Therapeutics Corporation to Report First Quarter 2022 Financial Results Before the Market Opens on Wednesday, May 4, 2022Business Wire • 04/27/22
United Therapeutics Announces the Publication of Tyvaso DPI™ BREEZE Clinical and Long-term Data in the Journal Pulmonary CirculationBusiness Wire • 04/06/22
United Therapeutics (UTHR) Moves 3.1% Higher: Will This Strength Last?Zacks Investment Research • 03/14/22
United Therapeutics Corporation to Present at the Oppenheimer 32nd Annual Healthcare ConferenceBusiness Wire • 03/08/22
United Therapeutics Corporation to Present at the Cowen 42nd Annual Health Care ConferenceBusiness Wire • 03/01/22
United Therapeutics Corporation (UTHR) CEO Martine Rothblatt on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 02/27/22
Down 14.1% in 4 Weeks, Here's Why You Should You Buy the Dip in United Therapeutics (UTHR)Zacks Investment Research • 02/25/22
United Therapeutics (UTHR) Misses Q4 Earnings and Revenue EstimatesZacks Investment Research • 02/24/22
United Therapeutics Corporation Reports Fourth Quarter and Full Year 2021 Financial ResultsBusiness Wire • 02/24/22
United Therapeutics Corporation to Report Fourth Quarter and Full Year 2021 Financial Results Before the Market Opens on Thursday, February 24, 2022Business Wire • 02/21/22
United Therapeutics Corporation Announces Historic Achievements in its Xenotransplantation ProgramsBusiness Wire • 01/21/22
United Therapeutics Corporation to Webcast Executive Fireside Chat Conversation With J.P. Morgan AnalystBusiness Wire • 12/30/21